Syngene extends research collaboration with Bristol Myers Squibb April 27, 2021 Tie up to extend through the end of 2030 Syngene International, an integrated research, development and manufacturing services company, has announced that it has extended its ongoing research collaboration with Bristol Myers Squibb. The collaboration has been extended through the end of 2030 and will expand the breadth of drug discovery research conducted, including chemistry, biology, drug metabolism and pharmacokinetics, as well as translational medicine research and pharmaceutical development, including chemi...